Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed SWOG-9143 A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma 8/15/1992 9/15/1994 100% Published
    Closed SWOG-9500 A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia 12/15/1995 4/1/1997 100% Published
    Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 28%
    Open S2005 A Phase II Randomized Study of Ibrutinib and Rituximab with or without Venetoclax in Previously Untreated Waldenstrom's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) 6/24/2021 3%
    Closed SWOG-9100 A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma 1/15/1993 8/1/1994 86% Published
    Closed SWOG-9107 A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer 1/1/1993 8/1/1994 70% Published
    Closed SWOG-8900 A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma 5/1/1989 12/1/1991 100% Published
    Closed SWOG-9246 A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma 3/1/1993 12/1/1995 58% Published
    Closed SWOG-9213 A Phase II Evaluation of Fazarabine for Patients with "Poor Prognosis” Extensive Stage Small Cell Lung Cancer 6/15/1993 6/15/1994 10%
    Closed SWOG-9006 A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract 10/15/1990 11/1/1996 77% Published
    Closed SWOG-9436 (NABTC-9403) (NCI T94-0184) A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma 4/18/1995 2/4/1998 95% Published
    Closed SWOG-9026 A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to… 7/15/1991 9/29/1992 100% Published
    Closed SWOG-9462 (NABTC-9404) (NCI T94-0034) A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy 7/28/1995 8/15/1997 90%
    Closed SWOG-8940 A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer 3/1/1990 11/1/1992 100% Published
    Closed SWOG-9112 A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2 7/15/1991 11/1/1992 3%
    Closed S9617 A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML). 11/1/1996 9/1/1998 100% Published
    Closed SWOG-9031 A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia 11/15/1991 1/15/1995 100% Published
    Closed SWOG-9032 A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia 6/1/1992 3/1/1998 100% Published
    Closed SWOG-9126 A Controlled Trial of Cyclosporine as a Chemotherapy- Resistance Modifier in High Risk Acute Myeloid Leukemia, Phase III 3/1/1993 3/1/1998 100% Published
    Closed SWOG-7519 A Comparison of Methotrexate with a Three-Drug Combination, Methotrexate, Methyl-CCNU & Bleomycin for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region 10/17/1975 3/1/1978
    Scroll Table